About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 Clinical Trials in Chicago | 116 Studies

Clinical Trials COVID-19Chicago

COVID-19 Clinical Trials in Chicago

Find 116 clinical trials for covid-19 near Chicago, Illinois. Connect with research centers in your area.

All COVID-19 trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 116 trials

Active not recruitingA Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)The main goal of this study is to characterize presentation, clinical course, and long-term outcomes of myocarditis temporally associated with administration of mRNA-1273…NCT06189053·Chicago, Illinois RecruitingA Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of AgeThis study will evaluate 2 dose levels of mRNA-1283 in participants ≥6 months to \<12 years to determine the optimal dose level per age group.NCT07808697·Ontario, California and 30 others

COVID-19 Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedRECOVER-AUTONOMIC Platform ProtocolThis study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be…NCT06305780·Opelika, Alabama and 49 others

TerminatedA Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and AdultsThe primary objective of the study is to evaluate the effect of casirivimab+imdevimab, compared with placebo, in preventing symptomatic SARS-CoV-2 infection in immunocompromised…NCT05074433·Birmingham, Alabama and 66 others

CompletedImproving Attention in Individuals With Long COVID-19This study is to find out if the Attention Processing Training program is a potential treatment for brain fog symptoms, reported by people with Long-Covid.NCT06503874·Chicago, Illinois

CompletedSafety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy PeopleThis was an exploratory Phase I, randomized, observer-blind, active-controlled, dose-escalation trial to evaluate four dose levels (DLs) of BNT162b4 given in combination with…NCT05541861·Tempe, Arizona and 16 others

CompletedCharacterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19The purpose of this study is to learn more about infection with and recovery from the virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).NCT04403880·Birmingham, Alabama and 52 others

CompletedStudy of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced PneumoniaThis was a multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of canakinumab plus standard-of-care (SOC) compared with placebo plus…NCT04362813·Birmingham, Alabama and 38 others

CompletedA Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of AgeThis study will evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concerns (VOCs) in…NCT05436834·Bessemer, Alabama and 73 others

CompletedStudy of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and OlderThe primary objectives of the study are: To assess the safety profile of the study vaccines in each study intervention group.NCT04762680·Birmingham, Alabama and 65 others

TerminatedA Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV_2 Spike and Nucleocapsid ProteinsPRIME-2-CoV\_Beta is the first clinical candidate based on the attenuated 2nd generation Orf virus (ORFV) vaccine platform which encodes for the structural spike (S)- and…NCT05367843·Florida City, Florida and 6 others

CompletedSARS-CoV-2/COVID-19 Prevalence StudyThe COVID-19 Prevention Network (CoVPN) is doing a study to estimate the number of people who have or have had the SARS-CoV-2 virus in different communities in the United States.NCT04658121·Aurora, Colorado and 14 others

CompletedA Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-1283.222 versus mRNA-1273.222…NCT05815498·Huntsville, Alabama and 229 others

RecruitingDysbiosis & Long COVIDThe SARS-CoV-2 virus causes COVID-19, which ranges from mild initial symptoms to severe multi-organ dysfunction.NCT06825819·Chicago, Illinois

TerminatedPBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19.NCT05543707·Mesa, Arizona and 53 others

CompletedAdaptive COVID-19 Treatment Trial 4 (ACTT-4)ACTT-4 will evaluate the combination of baricitinib and remdesivir compared to dexamethasone and remdesivir. Subjects will be assessed daily while hospitalized.NCT04640168·Birmingham, Alabama and 71 others

CompletedStudy of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized PatientsThe primary objective of this study is to evaluate the time to confirmed clinical recovery in participants hospitalized with COVID-19.NCT04590586·Anniston, Alabama and 58 others

TerminatedEfficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe PneumoniaThis study evaluated the efficacy, safety, pharmacokinetics, and pharmacodynamics of ravulizumab administered in adult participants with coronavirus disease 2019 (COVID-19) severe…NCT04369469·Little Rock, Arkansas and 38 others

CompletedLow vs. Moderate to High Dose Vitamin D for Prevention of COVID-19The purpose of this study is to compare the risks of COVID-19 in individuals from Chicagoland communities randomized to low (400 IU/day) vs. moderate (4,000 IU/day) or high…NCT04868903·Chicago, Illinois and 1 other

CompletedA Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and InfluenzaSubstudy A: This is a Phase 1 randomized, open-label study to describe the safety and immunogenicity of up to 3 dose- level combinations of modRNA quadrivalent influenza vaccine…NCT05596734·Athens, Alabama and 58 others

PreviousPage 4 of 6Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia